Clinical Trials Directory

Trials / Unknown

UnknownNCT03046173

Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach

Osteogenic Effects of Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach With Simultaneous Implant Placement: a Single-center Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Deyang Stomatological Hospital · Academic / Other
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

To investigate the effects of concentrated growth factors applied in maxillary sinus floor elevation via a lateral window approach with simultaneous implant placement on repair of bone defects and new bone formation.

Detailed description

Maxillary sinus floor elevation via a lateral window approach is the most effective method of overcoming the shortage of bone mass deficiency in atrophic maxillary posterior region. Bone transplantation is considered to be a prerequisite for the success of maxillary sinus floor elevation. Platelet-rich plasma and platelet-rich fibrin have been used to accelerate bone formation, regeneration, and repair. However, few in-depth studies are reported on the effects of concentrated growth factors on new bone formation.

Conditions

Interventions

TypeNameDescription
OTHERconcentrated growth factorsThese patients were randomly assigned to receive concentrated growth factors, hydroxyapatite and autogenous bone at bone defect sites in the experimental group.
OTHERhydroxyapatite and autogenous boneThese patients were randomly assigned to receive hydroxyapatite and autogenous bone at bone defect sites in the control group.

Timeline

Start date
2014-05-01
Primary completion
2016-01-01
Completion
2017-05-01
First posted
2017-02-08
Last updated
2017-02-08

Source: ClinicalTrials.gov record NCT03046173. Inclusion in this directory is not an endorsement.